This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Baxter Healthcare Sa, Baxter International Inc.. Active years: 2013-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2013-2014
Title: Deepak Tiwari: Innovator in Esmolol Formulations
Introduction
Deepak Tiwari is an accomplished inventor based in Raritan, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of esmolol compositions. With a total of 2 patents, Tiwari's work has the potential to enhance the efficacy and usability of esmolol in medical applications.
Latest Patents
Tiwari's latest patents include a multi-dose concentrate esmolol with benzyl alcohol. This invention discloses a concentrate esmolol injection that is essentially free from other related esters of esmolol and includes a formulation with concentrations ranging from about 25-1000 mg/ml of esmolol and about 1-25% w/v of benzyl alcohol. The compositions can be utilized as multi-dose formulations, and the invention also details methods for creating ready-to-use diluted compositions of esmolol. Another notable patent is the colored esmolol concentrate, which provides a formulation that is distinguishable from its diluted counterpart.
Career Highlights
Throughout his career, Deepak Tiwari has worked with prominent companies in the pharmaceutical industry, including Baxter International Inc. and Baxter Healthcare. His experience in these organizations has contributed to his expertise in drug formulation and development.
Collaborations
Tiwari has collaborated with notable professionals in his field, including George Owoo and Rekha Nayak. These collaborations have likely enriched his work and contributed to the innovative nature of his patents.
Conclusion
Deepak Tiwari's contributions to esmolol formulations demonstrate his commitment to advancing pharmaceutical science. His innovative patents reflect a deep understanding of drug composition and its practical applications in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile